![]() |
|
|
Vol. 53, Issue 4, 718-726, April 1998
Division of Biochemistry, Walter Reed Army Institute of Research, Washington, DC 20307-5100 (C.L., B.P.D.), and Israel Institute for Biological Research, Ness-Ziona, Israel (Y.A.)
| |
Summary |
|---|
|
|
|---|
Reactivation of organophosphate (OP)-inhibited acetylcholinesterase (AChE) by oximes is the primary reason for their effectiveness in the treatment of OP poisoning. Reactivation is reported to accelerate by quaternary ligands such as decamethonium, which is devoid of nucleophilicity. The mechanism of this enhancement is not known. To better understand the acceleration phenomenon, we examined ligand modulations of oxime-induced reactivation of methylphosphonylated AChE using 7-(methylethoxyphosphinyloxy)-1-methylquinolinium iodide and fetal bovine serum AChE. Edrophonium, decamethonium, and propidium, three quaternary AChE ligands of different types, were tested as potential accelerators. Experiments were carried out with both soluble enzyme preparation and AChE conjugated to polyurethane. Kinetic measurements with oximes 2-[hydroxyiminomethyl]-1-methylpyridinium chloride, 1,1'-trimethylene bis-(4-hydroxyimino methyl)-pyridinium dibromide, and 1,1'-[oxybis-methylene)bis[4-(hydroxyimino)methyl]pyridiniuum dichloride showed that in the presence of 50 µM edrophonium, the reactivation rate constants increased 3.3-12.0-fold; 200 µM decamethonium produced a 1.6-3.0-fold enhancement of reactivation rate constants by the same oximes. Reactivation of the inhibited enzyme by 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridinium)-dimethyl ether hydrochloride, 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(3-carboxy-aminopyridinium)-dimethyl ether hydrochloride, and 1-[[[4-(aminocarbonyl)pyridino]methoxy]methyl]-2, 4,-bis(hydroxyimino)methyl pyridinium dichloride was not affected by either ligand. Propidium slowed the reactivation of 7-(methylethoxyphosphinyloxy)-1- methylquinolinium iodide-inhibited AChE by all oximes. Results suggest that the accelerator site may reside inside the catalytic gorge rather than at its entrance and acceleration may be due to the prevention of reinhibition of the regenerated enzyme by the putative product, the phosphonylated oxime. In addition to the nucleophilic property of the oximate anion, some of the reactivators may carry an accelerating determinant, as characterized with respect to edrophonium and decamethonium. Results offer possible explanations for the superiority of 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridinium)-dimethyl ether hydrochloride over other oximes in the reactivation of specific AChE-OP conjugates.
| |
Introduction |
|---|
|
|
|---|
AChE
(EC 3.1.1.7), a serine hydrolase, catalyzes the hydrolysis of the
neurotransmitter acetylcholine and terminates impulse transmission at
cholinergic synapses. Acute toxicity of OP compounds is attributed to
irreversible inhibition of AChE, via covalent linkage to
-oxygen of
the active-site serine. Reactivation of inhibited AChE by nucleophiles
such as oximes is an efficient way to attenuate toxicity; it plays a
key role in the treatment of OP poisoning and has been the subject of
investigation for decades to find more effective reactivators for the
treatment of OP pesticide and chemical warfare agent toxicity.
Reactivation of inhibited enzyme depends on the OP moiety, the nature
and source of enzyme, and the structure of reactivator. In some cases,
changes in one factor result in significant enhancement or retardation of the reactivation rate constants. One strategy to improve efficacy of
reactivators is to characterize their structural features that accelerate displacement of OP-bound moiety and introduce them into
newly designed oximes.
Many studies have attempted to delineate interactions between oximes
and AChE-OP conjugates to find the structural features in oxime
molecules and inhibited enzyme that determine reactivatability (Ashani
et al., 1995
; Schwart et al., 1995; Grosfeld
et al., 1996
; Bencsura et al., 1995
, Saxena
et al., 1993
; Masson et al., 1997
). Some
investigators have also found that oxime-induced reactivation of
AChE-OP conjugates can be accelerated by the quaternary ligands decamethonium and SAD-128 (Harris et al., 1978
; Luo et
al., 1995
). This phenomenon was first observed in experiments with
human erythrocyte AChE using soman and sarin to obtain inhibited enzyme
(Harris et al., 1978
). These authors demonstrated that the
bisquaternary compound SAD-128 slowed the aging of soman-inhibited AChE
and thereby extended the period for oximes TMB4
and LüH6 to restore enzyme activity before
aging took place. No data for the enhancement of reactivation rate
constant were provided, but a relative increase in the fraction of the
reactivated enzyme was noted. Slowing of the rate of aging in the
presence of SAD-128 and other monoquaternary and bisquaternary ligands,
such as tetramethylammonium, suxamethonium, and hexamethonium, was
confirmed later (
talc and
entjurc, 1990
; Grubi
and
Tomazi
, 1989
; Szinicz and Hallek, 1988
). For sarin-inhibited
AChE, it was suggested that the enhancement of reactivation could not
be attributed to the same mechanism proposed for soman-inhibited enzyme
because of the slow aging of AChE-sarin conjugate. Explanations such as
decreasing the rate of inhibition by parent OP or conformational
changes due to tight binding of these ligands at the peripheral site of
the enzyme were suggested (Harris et al., 1978
). Because in
none of these experiments were residual OPs completely removed before
the addition of the oxime and the accelerating ligand, it is difficult
to provide a straightforward explanation for the results, and the
mechanism of acceleration phenomenon remains unclear. Interpretation of
reactivation data is complicated by several parallel reactions:
reactivation of inhibited enzyme, reinhibition of regenerated enzyme by
putative POX (Fig. 1) (Hackley et
al., 1959
, Schoene, 1972
; Harvey et al., 1986a
, 1986b
;
Ashani et al., 1995
), and the possibility of different allosteric effects exhibited by the ligands used.
|
To clarify the mechanism of ligand-induced acceleration of oxime
reactivation, we examined the effect of several quaternary ligands on
the reactivation of MEPQ-inhibited FBS AChE (Fig. 1). MEPQ (Levy and
Ashani, 1986
) was used to inhibit the enzyme for the following reasons.
(1) The high bimolecular inhibition rate constant permits a
near-stoichiometric inhibition protocol using relatively low
concentrations of reactants. (2) Inhibited AChE does not readily age.
(3) The OP/enzyme conjugate EMP-AChE represents a series of
methylphosphonyl-AChE conjugates obtained with methylphosphonofluorides such as soman and sarin. FBS AChE is available in relatively large quantities as purified enzyme, and much experimental data have been
accumulated on its inhibition and reactivation characteristics (Ashani
et al., 1990
; Wolfe et al., 1994
). Sequence
alignment suggests that the amino acid residues lining the active-site
gorge of FBS and human AChEs are identical (Cygler et al.,
1993
). Three reversible ligands, edrophonium, decamethonium, and
propidium, which interact with AChE by different mechanisms (Taylor and
Lappi, 1975
; Radi
et al., 1991
; Harel et
al., 1993
; Barak et al., 1994
), were studied for their
effects on the reactivation of MEPQ-inhibited FBS AChE by various oxime
reactivators. Time courses of oxime-induced reactivation were
monitored, and the second-order reactivation rate constants were
determined with and without accelerating ligands. In an attempt to
remove the putative reactivation byproduct POX from the
microenvironment of the enzyme during reactivation, FBS AChE
immobilized on polyurethane sponge was used. Results shed light on the
effects of added ligands on oxime-induced reactivation and provide
clues for explaining the differences observed in the reactivation
potency of various oximes.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
MEPQ was prepared according to a previously
reported procedure (Levy and Ashani, 1986
). 2-PAM,
TMB4, LüH6
(toxogonin), HI-6, HS-6, HLo7, and MMB4 (Fig. 1)
were obtained from the Division of Experimental Therapeutics, Walter
Reed Army Institute of Research (Washington, DC). Decamethonium and
propidium were purchased from Sigma Chemical (St. Louis, MO).
Electrophoretically pure FBS AChE (5000 units/mg; 1 unit of enzyme will
hydrolyze 1.0 µmol/min acetylcholine at pH 8.0 at 25°) was prepared
in our laboratory according to a method reported previously (De La Hoz
et al., 1986
). Bio-Spin 6 chromatography columns were
purchased from BioRad (Hercules, California); FBS AChE sponge was
prepared by covalent linking of the tetrameric form of the enzyme to
the polyurethane foam (LeJeune et al., 1996
).
AChE assay.
FBS AChE activity was determined
spectrophotometrically according to the method of Ellman et
al. (1961)
. One nanomole of FBS AChE has 400 units of activity.
The assay mixture (3.2 ml) contained 1 mM ATC as substrate
and 1 mM DTNB in 50 mM phosphate buffer, pH
8.0. All measurements were performed at 25°.
Determination of dissociation constants of the complex between
native FBS AChE and oxime.
Dissociation constants for complexes
involved in the reversible inhibition of native FBS AChE by oximes were
determined as described previously (Ashani et al., 1995
).
Briefly, increasing concentrations of ATC were added to FBS AChE that
was preincubated with various concentrations of oxime and 1 mM DTNB in 50 mM phosphate buffer, pH 8.0, at
25°. Activities were corrected for oxime-catalyzed hydrolysis of ATC.
Plot of 1/V versus 1/S (Lineweaver-Burk plot) yielded a series of
straight lines with different slopes. The slopes of these lines were
replotted against the oxime concentration. The
Kox value was determined from the
x intercept of the straight lines obtained from the
secondary plot.
Dose-response profiles of acceleration by quaternary
ligands.
To 0.75 unit of FBS AChE in 50 mM phosphate
buffer, pH 8.0, containing 0.05% BSA, a stoichiometric amount of MEPQ
was added to ensure ~98% inhibition of enzyme activity. The mixture,
in a final volume of 50 µl, was incubated at 25° for 1 hr. To
reactivate the enzyme, 1 mM oxime was added with or without
the quaternary ligand to be tested and further incubated for 15 min at
25° in a total volume of 100 µl (final concentration of the enzyme,
18.75 nM). The incubation mixture was applied to a
prewashed Bio-Spin 6 chromatography column and immediately centrifuged
at 1000 × g for 2 min. Control experiments based on
inhibition of fresh FBS AChE solution by the column effluent clearly
showed that all the three reversible ligands, at concentrations as high
as 1 mM, could be effectively removed by this technique.
Control enzyme samples were treated in the same manner except that no
MEPQ was added to the enzyme solution. Enzyme activity of the sample
was determined as described above. Percent reactivation was
calculated as described previously (Ashani et al., 1995
).
Determination of reactivation rate constants in the presence and absence of accelerating ligands. A substoichiometric amount of MEPQ (sufficient to inhibit ~90% of enzyme activity) was added to 2.5 units of FBS AChE in a final volume of 50 µl of 50 mM phosphate buffer, pH 8.0, containing 0.05% BSA and incubated for 1 hr at 25°. The incubation mixture was diluted 10-fold with the same buffer to produce a final concentration of 12.5 nM enzyme. This minimized the effects of residual MEPQ on the reactivation rate. The final oxime concentration in the reactivation mixture ranged from 10 µM to 3 mM. At specified time intervals, 10 µl of reactivation mixture was withdrawn and diluted into 3.2 ml of assay mixture to monitor the change in enzyme activity. The reactivation rate constants in the presence of accelerators were determined using 50 µM edrophonium or 200 µM decamethonium. These concentrations caused only marginal inhibition of the enzyme activity (<5%) after dilution in the assay buffer.
Due to the chirality of the phosphorus in MEPQ, the phosphonyl conjugate EMP-AChE consists of two stereoisomers that are reactivated at different rates. The reactivation rates were calculated assuming an equal distribution of the two components of conjugated enzyme under the conditions used for the inhibition. Regression and statistical analyses were performed using Prism Version 2.0, 1995 (GraphPAD Software, San Diego, CA).Determination of the dissociation constant of the complex between
edrophonium and AChE-OP conjugate.
To estimate the dissociation
constant of the complex between the accelerator and the inhibited
enzyme, the following kinetic scheme was used in accordance with the
assumptions made by Kitz and Wilson for the acceleration of the
methanesulfonylation of AChE by substituted ammonium cations (Kitz and
Wilson, 1963
).
|
(1) |
|
(2) |
= ka/kr.
Assay of enzyme activity of FBS AChE immobilized on polyurethane foam (sponge). We cut 10 mg of sponge (containing ~0.1 unit of enzyme activity) into small pieces and placed them into 10 ml of 50 mM phosphate buffer, pH 8.0. To the sponge suspension, 0.33 ml of 30 mM ATC was added and mixed thoroughly for 5 min. An aliquot of 1.033-ml supernatant was transferred to a cuvette with 33 µl of 30 mM DTNB, and the absorbance at 412 nm was measured immediately. Enzyme activity is expressed as units of activity/g of sponge.
Reactivation of MEPQ-inhibited FBS AChE immobilized on sponge. We placed 10 mg of sponge into 1 ml of 0.375 µM MEPQ solution for 30 min to inhibit >98% of AChE activity. The sponge was washed twice with 10 ml of 50 mM phosphate buffer, pH 8.0, and packed into a 3-mm internal diameter column. The column was washed with either reactivator/buffer solution or reactivator/ligand/buffer solution at a flow rate of 2 ml/min. After 15 min, the column was washed with 50 mM phosphate buffer, pH 8.0. The sponge was extruded from the column and assayed for enzyme activity as described above. Controls were treated in the same way except that no OP was added.
| |
Results |
|---|
|
|
|---|
Dissociation constants of FBS AChE-oxime complexes. Lineweaver-Burk plots for most of the oximes revealed competitive inhibition. Kox values (mM) determined from the slopes of Lineweaver-Burk plot versus oxime concentrations were as follows (standard error <25%): 2-PAM, 0.16; TMB4, 0.037; LüH6, 0.4; MMB4, 0.90; HI-6, 0.09; HS-6, 0.22; and HLo7, 0.042.
Spontaneous reactivation of EMP-AChE in the presence of different quaternary ligands. MEPQ-free phosphonylated enzyme was obtained by gel filtration using Bio-Spin column chromatography. Control experiments showed that residual OP could be completely removed from the inhibited enzyme by this procedure. No significant acceleration of the spontaneous reactivation of EMP-AChE could be observed in the first 2 hr of incubation in presence of 20 µM propidium, 50 µM edrophonium, or 200 µM decamethonium (Fig. 2). However, on prolonged incubation (22 hr), it seemed that the three ligands produced different effects on spontaneous reactivation. Edrophonium more than doubled the spontaneous reactivation rate of the AChE-OP conjugate; decamethonium did not change the rate; and propidium decreased the spontaneous reactivation rate by <50%. However, these changes were essentially negligible compared with changes observed in oxime-induced reactivation with the same ligands.
|
Effect of increasing concentration of quaternary ligands on oxime-induced reactivation of EMP-AChE. A dose-response acceleration of reactivation of EMP-AChE was observed with edrophonium and decamethonium. Edrophonium displayed a remarkable enhancement of reactivation by 2-PAM, TMB4 and LüH6 (Fig. 3, A-C) in the concentration range of 10 µM to 1 mM and produced a greater acceleration than decamethonium. The peripheral-site ligand propidium slowed the reactivation process with all oximes tested, also in a concentration-dependent manner. None of the ligands could promote HI-6-induced reactivation of the phosphonylated enzyme (Fig. 3D). In these experiments, the concentration of the leaving group product of MEPQ, 7-HQ, was present at ~18 nM. In control experiments with a 7-HQ-free inhibited enzyme obtained by gel filtration, the reactivation measured was similar to that observed in the presence of 7-HQ. Therefore, at the specified concentration, it did not significantly affect the results.
|
Kinetic rate constants for the reactivation of EMP-AChE in the presence of accelerators. Although minor deviations occurred at low concentrations of TMB4 and LüH6, in most cases the data fitted well to an exponential association equation for the two-component model in the determination of first-order reactivation rate constant, kobs. The magnitudes of kobs values for the fast reactivation component of the inhibited enzyme were usually several-fold larger than those of the slow reactivation component.
Secondary plots of kobs versus oxime concentration were used to obtain the second-order reactivation rate constants. Plot of kobs versus oxime concentration is expected to yield a curve that asymptotically approaches a constant value when the concentration of oxime is sufficiently high. This was the case only for 2-PAM and HI-6, and the bimolecular rate constants (kr) were obtained by dividing the unimolecular rate constant (k'max) by the dissociation constant of the phosphonylated enzyme/oxime complex, K'ox (Fig. 1). Because the plots for TMB4 and LüH6 resulted in straight lines, the bimolecular rate constants of the reactivation by these oximes were calculated from the slope of the line for the concentration range used. Reactivation rate constants of EMP-AChE by 2-PAM, HI-6, TMB4, and LüH6 in the absence and presence of edrophonium and decamethonium are summarized in Table 1. In the presence of 50 µM edrophonium, the bimolecular rate constants for the fast reactivation component of the EMP/AChE conjugate by 2-PAM, TMB4, and LüH6 increased 3.3-, 5.3-, and 4.5-fold, respectively. A greater increase in the reactivation constant of the slow component was observed with TMB4 and LüH6 (8.7- and 12.0-fold, respectively). No changes in kr could be detected with HI-6. In the presence of 200 µM decamethonium, similar acceleration effects were observed as for edrophonium, but to a lesser degree; the bimolecular rate constants of both the fast and slow components were changed 1.6-3-fold. Again, no distinct changes were observed in the reactivation rate constant of EMP-AChE by HI-6 in the presence of 200 µM decamethonium.
|
Dissociation constant of the complex between edrophonium and
EMP-AChE.
The plot of the ratio of the edrophonium-accelerated
rate constant over the normal rate constant (i.e.,
kobs/kr)
versus edrophonium concentration is shown in Fig.
4. The saturation curves imply that the
acceleration phenomenon may be peculiar to an enzyme-ligand interaction. The dissociation constants
(Ka) of the complex between edrophonium and the inhibited enzyme were 20.6 ± 4.8 µM (
= 10.7) and 19.5 ± 3.5 µM (
= 14.3) for the reactivation of the
fast component of EMP-AChE with TMB4 and
LüH6, respectively.
|
Dependence of the edrophonium-induced acceleration on the initial
concentration of the phosphonylated enzyme.
Because reactivation
can be slowed by reinhibition of the regenerated enzyme by POX, a
product that may have accumulated during reactivation (Fig. 1), and
because the stability of this intermediate depends on the oxime used
(Hackley et al., 1959
; Schoene, 1972
; Harvey et
al., 1986b
), it was important to examine the dependence of the
acceleration on the initial concentration of the phosphonylated enzyme.
It was assumed that an increase in the concentration of the inhibited
enzyme at a fixed oxime concentration would increase the concentration
of POX, which in turn could decrease the overall rate of reactivation.
This allowed the examination of the relationship between the
acceleration and POX reinhibition of various oximes. For this purpose,
the time courses of reactivation with TMB4, LüH6, 2-PAM, MMB4,
HI-6, HS-6, and HLo7 were monitored at initial concentrations of 1.25 and 12.5 nM of EMP-AChE, with and without 50 µM edrophonium. The results for
TMB4, LüH6, 2-PAM,
and HI-6 are shown in Fig. 5. Results of
MMB4 resemble those of 2-PAM, and those of HS-6
and HLo7 are almost identical with those of HI-6 (data not shown).
|
Enhancement of oxime-induced reactivation by edrophonium and decamethonium in FBS AChE conjugated to polyurethane sponge. To examine further the hypothesis that the observed acceleration was due to a decrease in reinhibition of free enzyme by POX, immobilized FBS AChE was used to remove continuously low-molecular-weight ligand produced during the reactivation process. Under such conditions, reinhibition of the reactivated enzyme by POX was expected to attenuate. For this purpose, a modified Ellman procedure was developed for assaying enzyme activity in the sponge. Plot of absorbance at 412 nm versus time provided a straight line over the first 5 min (not shown).
Fig. 6 shows reactivation results obtained with FBS AChE sponge inhibited with MEPQ and eluted continuously for 15 min with 0.1 mM 2-PAM, LüH6, TMB4, or HI-6 in the presence or absence of the accelerating ligands. The reactivation of the immobilized enzyme was distinctively faster than with enzyme in homogenous solution. Nearly the same level of reactivation could be achieved with one tenth of the oxime concentration used in the experiments with EMP-AChE in solution. Although no attempt was made to obtain rate constants for the reactivation of AChE conjugated to sponge, the acceleration effect of edrophonium and decamethonium on oxime-induced reactivation was still discernible, and enhancement of reactivation followed the same rank order as that observed for enzyme in solution.
|
| |
Discussion |
|---|
|
|
|---|
An important finding of this study was that among the three types
of ligands tested, the active-site ligand edrophonium is the most
powerful accelerator of oxime-induced reactivation of EMP-AChE. This
acceleration was quite substantial, and with 50 µM
edrophonium, the bimolecular rate constant of the reactivation by
LüH6 was increased 12-fold. Decamethonium,
which spans the peripheral- and active-site region (Taylor and Jacobs,
1974
; Harel et al., 1993
; Barak et al., 1994
),
was less potent. The peripheral-site ligand propidium not only lacked
acceleration properties but also slowed the reactivation of
MEPQ-inhibited FBS AChE (Fig. 3). This is reasonable because binding of
propidium to the peripheral site may sterically or allosterically
prevent the oxime from entering into the active site of the enzyme, as
occurs in substrate hydrolysis (Barak et al., 1995
). These
observations suggest that the acceleration site may reside near the
catalytic center inside the gorge rather than near the entrance. The
fact that edrophonium lacks nucleophilicity, as judged from its
negligible effect on spontaneous reactivation, rules out the
possibility that the accelerator directly attacks the P atom of the
enzyme-bound EMP moiety. The probability that the hydroxyl group of
edrophonium is involved in the acceleration of the displacement of OP
moiety by oximes is decreased in light of the structure of other
accelerators, such as decamethonium and SAD-128 (Harris et
al., 1978
; Luo et al., 1995
).
Studies of inhibition of FBS AChE-catalyzed hydrolysis of acetylcholine
by edrophonium provided a dissociation constant
(KI) of 0.1-0.2
µM (Ashani et al., 1990
; Saxena
et al., 1997
). If the accelerator site is the same as the
binding site of edrophonium to the native enzyme, the dissociation
constant obtained from the acceleration experiments,
Ka, would be expected to be in the same range. Although the Ka values
for the acceleration in experiments with TMB4 and
LüH6 were in excellent agreement (20.6 ± 4.8 and 19.5 ± 3.5 µM, respectively),
they indicate that the complex EMP-AChE··A is
100-200-fold less
stable than that formed between the native enzyme and edrophonium. This
is consistent with eq. 1 that assumed the binding of the accelerator to
EMP-AChE. The binding site of edrophonium was determined on the basis
of X-ray crystallography of its complex with native Torpedo
AChE and studies with AChE mutants (Harel et al., 1993
;
Barak et al., 1994
; Ordentlich et al., 1995
). The
amino acid residues shown to interact with edrophonium in the native
enzyme may not be available to stabilize edrophonium in the EMP-AChE
conjugate (i.e., the active-site serine, the oxyanion constituents, and
possibly the catalytic histidine). Indeed, the complex of edrophonium
with some aged and nonaged OP conjugates of AChE was found to be
100-1000-fold less stable than the complex with native enzyme (Berman
and Decker, 1986a
, 1986b
). The dissociation constant,
Ka, from our experiments indicates
that the stability of EMP-AChE·A is still 30-fold greater than the
complex formed between edrophonium and the peripheral anionic site of
mouse AChE (KI = 590 µM) (Radi
et al., 1991
). This
substantiates the conclusion that the accelerator site is close to the
catalytic center of the enzyme. Although the experimental evidence
suggests that the accelerator binding may be inside the gorge, it is
difficult to designate a specific attachment locus.
Assuming that acceleration arises from binding of edrophonium near the catalytic site region, the next questions to be addressed are: By what mechanism does the ligand enhance the reactivation by 2-PAM, MMB4, TMB4, and LüH6? Why is reactivation by HI-6, HS-6, and HLo7 not affected? At first, eq. 1 seems to offer a straightforward answer that is peculiar to conformational changes in the phosphonylated enzyme after the binding of the accelerator to the inhibited enzyme. According to this explanation, it is likely then that HI-6, HS-6, and HLo7 already are projected inside the gorge in orientations that do not require assistance of an accelerating ligand. However, not all results are consistent with an allosteric mechanism, and some observations that offer other explanations for the acceleration phenomenon are discussed.
Relationship between EMP-AChE concentration and rate of
reactivation.
From the results of the seven tested oximes, it
clearly was shown that the dependence of reactivation on initial enzyme
concentration correlated very well with edrophonium acceleration of the
reactivation. Reinhibition by POX has been implied to explain the
decrease in the rate of reactivation of concentrated OP-AChE solutions
compared with diluted conjugates (Harvey et al., 1986b
;
Ashani et al., 1995
). Because the inability of edrophonium
to accelerate reactivation by HI-6, HS-6, and HLo7 parallels the lack
of dependence of reactivation by these oximes on the initial
concentration of EMP-AChE, it is possible that in addition to the
mechanism summarized in eq. 1, acceleration is manifested by slowing
the reinhibition by POX. Numerous reports have demonstrated protection
of AChE against OP inhibition by preincubation of the enzyme with a
reversible active-site ligand (Gray, 1984
; Galli et al.,
1994
; Grunwald et al., 1994
). The formation of a stable
reversible complex between AChE and a ligand that arrests the catalytic
machinery of AChE precludes phosphonylation of the active-site serine
and increases the chances of hydrolytic inactivation of the OP
inhibitor. However, for this hypothesis to hold, the 100-200-fold
differences between Ka and
KI must be considered. This
discrepancy may be reconciled by comparing the ratio
[accelerator]/Ka with
[oxime]/Kox.
[Accelerator]/Ka versus
[oxime]/Kox.
The results suggest that a
ternary complex among EMP-AChE, oxime, and edrophonium may be formed
and result in conformational changes that can underlie the observed
acceleration. If the enhancement of reactivation is due to protection
of the free enzyme from reinhibition, it also is possible for binding
of the reactivator to free enzyme to destabilize the complex AChE·A.
Therefore, Ka in eq. 1 is a macroscopic composite of more than one constant. Hence, the kinetic assumptions are more complex than those depicted in eq. 1. This can
explain the relatively high Ka values
compared with the KI values of
edrophonium for free enzyme. These considerations, together with the
structural similarities between reactivators and accelerators (Fig. 1),
raise the possibility that quaternary oximes are likely to carry their
own accelerating determinant, and their binding site may overlap the
accelerator site. Although oximes are poor inhibitors of the enzyme,
they still can competitively inhibit the enzyme, with the dissociation
constant, Kox, ranging from 0.037 to 0.90 mM. The ratio of edrophonium concentration to its Ka value (2.5) is significantly more
favorable in terms of occupying the accelerator site than the ratio
[oxime]/Kox for TMB4 and
LüH6 (<1.4; Fig. 5). For 2-PAM and HI-6,
these ratios were 3.1 and 5.6, respectively. Thus, the rank order of
the responsiveness of these four oximes to the acceleration phenomenon,
TMB4 ~ LüH6 > 2-PAM
HI-6, may be attributed to their partial occupation of the
accelerator site. However, these observations are not consistent with
[oxime]/Kox ratios of HLo7 (1.19) and HS-6
(2.27), which were not affected at all, or
[oxime]/Kox of MMB4
(0.05), which was only moderately accelerated by 50 µM edrophonium (not shown).
Stability of the putative POX.
The possibility that
differences in the stability of the reactivation product POX might
explain the results also was considered. This hypothesis is supported
two ways. First, as indicated, no unambiguous correlation was found
between the [oxime]/Kox ratio and the
acceleration produced by 50 µM edrophonium, suggesting that the diverse response of the oximes to the accelerator was only
partly influenced by the ability of edrophonium to compete with the
oxime for an accelerator site. Second, POX derived from an oxime at
position 2 of the pyridinium ring is significantly less stable than its
4 position homologue (Hackley et al., 1959
). Also, insertion
of a second quaternary ammonium head, such as found in the
2-hydroximinomethyl containing reactivators HI-6, HS-6, and HLo7, is
expected to further destabilize the 2-positioned phosphonylated oxime
due to the increase in the positive charge density. The latter is known
to facilitate nucleophilic displacements at the P atom. These arguments
agree well with the observation that reactivation was not enhanced by
accelerators, when HI-6, HS-6, and HLo7 were used, and support the
contention that the stability of POX can determine the oxime
responsiveness to the accelerating ligands.
Reactivation of sponge-bound AChE.
The results with the
immobilized EMP-AChE in sponge clearly showed that reactivation was
faster than with EMP-AChE in solution, an observation that
substantiates the proposed involvement of POX in the apparent rate of
reactivation and presumably in the acceleration phenomenon. Enhancement
of reactivation in the presence of edrophonium and decamethonium
followed the same rank order that was observed for soluble enzyme. It
seems that if POX indeed influences the reactivation time course, this
inhibitor is only partly accessible to washout from the column, and
edrophonium and decamethonium therefore can still exhibit partial
acceleration on the reactivation. This is supported by a recent study
of the reactivation of a diethylphosphoryl-butyrylcholinesterase
conjugate by 2-PAM in the absence and presence of an OP hydrolase
(Ashani et al., 1997
), which suggests that the putative POX
inside the catalytic gorge may not be accessible to the OP hydrolase
outside the gorge.
| |
Acknowledgments |
|---|
We thank Mary Kay Gentry for help in preparation of the manuscript.
| |
Footnotes |
|---|
Received October 9, 1997; Accepted December 29, 1997
1 Current affiliation: Institute of Pharmacology and Toxicology of Beijing, Beijing, China.
C.L. is the recipient of a National Research Council Associateship at the Walter Reed Army Institute of Research.
Send reprint requests to: Bhupendra P. Doctor, Ph.D., Division of Biochemistry, Walter Reed Army Institute of Research, Washington, DC 20307-5100. E-mail: dr._bhupendra_doctor{at}wrsmtp-ccmail.army.mil
| |
Abbreviations |
|---|
AChE, acetylcholinesterase; FBS, fetal bovine serum; OP, organophosphate; POX, phosphonylated oxime; MEPQ, 7-(methylethoxyphosphinyloxy)-1-methylquinolinium iodide; EMP, O-ethyl methylphosphonyl; 7-HQ, 7-hydroxy-1-methyl quinolinium cation; ATC, acetylthiocholine; DTNB, 5,5-dithiobis-(2-nitrobenzoic acid); SAD-128, 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride); 2-PAM, 2-[hydroxyiminomethyl]-1-methylpyridinium chloride; TMB4, 1,1'-trimethylene bis-(4-hydroxyimino methyl)-pyridinium dibromide; LüH6 (toxogonin), 1,1'-(oxybis-methylene)bis[4-(hydroxyimino)methyl]pyridinium dichloride; HI-6, 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridinium)-dimethyl ether hydrochloride ; HS-6, 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(3-carboxy-aminopyridinium)-dimethyl ether hydrochloride ; HLo7, 1-[[[4-(aminocarbonyl)pyridino]methoxy]methyl]-2, 4,-bis(hydroxyimino)methyl pyridinium dichloride ; MMB4, 1,1'-methylene bis[4-(hydroxyiminomethyl)pyridinium dibromide.
| |
References |
|---|
|
|
|---|
Z,
Tsigelny I,
Vellom DC,
Pickering N,
Quinn DM,
Doctor BP and
Taylor P
(1995)
Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
J Biol Chem
270:
6370-6380
Z and
Tomazi
(1989)
A mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2.
Arch Toxicol
63:
68-71[Medline].
Z,
Reiner E and
Taylor P
(1991)
Role of the peripheral anionic site on acetylcholine-esterase: inhibition by substrate and coumarin derivatives.
Mol Pharmacol
39:
98-104[Abstract].
talc A and
entjurc MA
(1990)
Contribution to the mechanism of action of SAD-128.
Biochem Pharmacol
40:
2511-2517[Medline].This article has been cited by other articles:
![]() |
P. I. Hammond, C. Kern, F. Hong, T. M. Kollmeyer, Y.-P. Pang, and S. Brimijoin Cholinesterase Reactivation in Vivo with a Novel Bis-Oxime Optimized by Computer-Aided Design J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 190 - 196. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||